Mitolactol - CISMeF

Preferred Label : Mitolactol;

NCIt synonyms : 6-Dibromodulcitol; Dibromdicil; Dibromodulcitol; 6-Dibromodideoxydulcitol; DBD;

NCIt related terms : Elobromol;

NCIt definition : A synthetic derivative of hexitol with antineoplastic and radiosensitizing properties. Mitolactol alkylates DNA via actual or derived epoxide groups, resulting in inhibition of DNA and RNA synthesis. (NCI04);

Alternative definition : NCI-GLOSS: An anticancer drug that belongs to the family of drugs called alkylating agents.;

UNII : LJ2P1SIK8Y;

InChIKey : VFKZTMPDYBFSTM-GUCUJZIJSA-N;

CAS number : 10318-26-0; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 10318-26-0 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

Drug name : Mitolac; Elobromol;

Chemical formula : C6H12Br2O4;

NSC code : 104800;

Codes from synonyms : CDR0000045191; NSC0104800;

Details

Origin ID

C662;

UMLS CUI

C0026252;

Automatic exact mappings (from CISMeF team)
- 4,4'-dibenzamido-2,2'-stilbenedisulfonic acid [MeSH Supplementary Concept]
- 4,4'-dibenzamido-2,2'-stilbenedisulfonic acid [MeSH concept]
- DBD ID [EDAM data]
- Dibromodulcitol [ICHI extension code]
- Mitolactol [ICHI extension code]
Currated CISMeF NLP mapping
- Mitolactol [ICD-11 Extension code]
- mitolactol [MeSH Descriptor]
- mitolactol [MeSH concept]
See also inter- (CISMeF)
- Dibromodulcitol [ICD-11 Extension code]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Mitolactol [ICD-11 Extension code]
- mitolactol [MeSH concept]
- mitolactol [MeSH Descriptor]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
- GDC Terminology [NCIt concept]
- GDC Therapeutic Agent Terminology [NCIt concept]
- GDC Value Terminology [NCIt concept]
- NCI Drug Dictionary Terminology [NCIt concept]
- NCIt Antineoplastic Agent Terminology [NCIt concept]
is_component_of_chemotherapy_regimen
- Altretamine/Doxorubicin/Fluoxymesterone/Methotrexate/Mitolactol/Prednisone/Tamoxifen/Vincristine [NCIt concept]
- Carmustine/Mitolactol [NCIt concept]
- Cisplatin/Mitolactol [NCIt concept]
- Cyclophosphamide/Fluoxymesterone/Mitolactol/Prednisone/Tamoxifen [NCIt concept]
- DAVH Regimen [NCIt concept]
- Doxorubicin/Fluoxymesterone/Methotrexate/Mitolactol/Tamoxifen/Vincristine [NCIt concept]
- Doxorubicin/Fluoxymesterone/Mitolactol/Tamoxifen [NCIt concept]
- Doxorubicin/Fluoxymesterone/Mitolactol/Tamoxifen/Vincristine [NCIt concept]
- Doxorubicin/Mitolactol [NCIt concept]
- Fluorouracil/Methotrexate/Mitolactol/Prednisone [NCIt concept]
- Fluoxymesterone/Mitolactol/Mitoxantrone/Tamoxifen [NCIt concept]
- Lomustine/Mitolactol/Procarbazine/Thioguanine [NCIt concept]
- Mitolactol/Doxorubicin/Vincristine Regimen [NCIt concept]
- Mitolactol/Mitoxantrone/Vincristine [NCIt concept]
- TPDCV Regimen [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients